NCT01521455View on ClinicalTrials.gov

Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

February 29, 2012

Primary Completion Date

June 30, 2013

Study Completion Date

July 31, 2013

Conditions
Asthma
Interventions
DRUG

HCP0910

250/50, BID for 2 weeks

DRUG

Seretide Diskus

250/50, BID for 2 weeks

Trial Locations (7)

Unknown

Soon Chun Hyang University Hospital Bucheon, Bucheon-si

Ajou University Hospital, Suwon

Asan Medical Center, Seoul

Ewha Womans University Medical Center, Seoul

Hanyang University Hospital, Seoul

Samsung medical center, Seoul

Seoul National University, Seoul

Sponsors
All Listed Sponsors
lead

Hanmi Pharmaceutical Company Limited

INDUSTRY

NCT01521455 - Therapeutic Equivalence Study of HCP0910 250/50 Mcg to Seretide 250 Diskus in Asthmatic Patients | Biotech Hunter | Biotech Hunter